Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 7 of 79

  1. The development of both chronic obstructive pulmonary disease (COPD) and lung cancer (LC) is influenced by smoking related chronic pulmonary inflammation caused by an excessive innate immune response to smoke ...

    Authors: Janna Berg, Ann Rita Halvorsen, May-Bente Bengtson, Kristin A. Taskén, Gunhild M. Mælandsmo, Arne Yndestad, Bente Halvorsen, Odd Terje Brustugun, Pål Aukrust, Thor Ueland and Åslaug Helland
    Citation: BMC Cancer 2018 18:739
    Content type: Research article Published on:

  2. Anemia refers to low hemoglobin (Hb) level and is a risk factor of cancer patient survival. The National Comprehensive Cancer Network recently suggested that post-diagnosis Hb change, regardless of baseline Hb...

    Authors: Shaogui Wan, Yinzhi Lai, Ronald E Myers, Bingshan Li, Juan P Palazzo, Ashlie L Burkart, Guokai Chen, Jinliang Xing and Hushan Yang
    Citation: BMC Cancer 2013 13:340
    Content type: Research article Published on:

  4. Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common ...

    Authors: Emilie Thivat, Sophie Thérondel, Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Emilie Gadéa, Eloïse Planchat, Fabrice Kwiatkowski, Marie A Mouret-Reynier, Philippe Chollet and Xavier Durando
    Citation: BMC Cancer 2010 10:648
    Content type: Research article Published on:

  5. In recent years, multiple coagulation and fibrinolysis (CF) indexes have been reported to be significantly related to the progression and prognosis of some cancers.

    Authors: Peng Yunpeng, Yin Lingdi, Zhu Xiaole, Huang Dongya, Hu Le, Lu Zipeng, Zhang Kai, Hou Chaoqun, Miao Yi, Guo Feng and Li Qiang
    Citation: BMC Cancer 2023 23:548
    Content type: Research Published on:

  6. Tumor microenvironment is composed of tumor cells, fibroblasts, endothelial cells, and infiltrating immune cells. Tumor-associated immune cells may inhibit or promote tumor growth and progression. This study w...

    Authors: Fuqiang Dai, Lunxu Liu, Guowei Che, Nanbin Yu, Qiang Pu, Shangfu Zhang, Junliang Ma, Lin Ma and Zongbing You
    Citation: BMC Cancer 2010 10:220
    Content type: Research article Published on:

  7. Granulocyte colony-stimulating factor (G-CSF)-producing lung cancer induces severe inflammation and a high white blood cell (WBC) count and is associated with poor prognosis. A recent case of G-CSF-producing l...

    Authors: Kazuhito Miyazaki, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Yusuke Hamakawa, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Yukiko Nakamura, Tsuneo Shimokawa and Hiroaki Okamoto
    Citation: BMC Cancer 2022 22:977
    Content type: Research Published on:

  9. Local consolidative treatment (LCT) is important for oligometastasis, defined as the restricted metastatic capacity of a tumor. This study aimed to determine the effects and prognostic heterogeneity of LCT in ...

    Authors: Jia-Tao Zhang, Si-Yang Liu, Hong-Hong Yan, Yi-Long Wu, Qiang Nie and Wen-Zhao Zhong
    Citation: BMC Cancer 2019 19:1051
    Content type: Research article Published on:

  10. This study aims to investigate the expression of UBQLN1 in lung cancer (LC) tissue and the diagnostic capability of autoantibody to UBQLN1 (anti-UBQLN1) in the detection of LC and the discrimination of pulmona...

    Authors: Yulin Wang, Songyun Ouyang, Man Liu, Qiufang Si, Xue Zhang, Xiuzhi Zhang, Jiaqi Li, Peng Wang, Hua Ye, Jianxiang Shi, Chunhua Song, Kaijuan Wang and Liping Dai
    Citation: BMC Cancer 2024 24:283
    Content type: Research Published on:

  11. Recent refinements of lung MRI techniques have reduced the examination time and improved diagnostic sensitivity and specificity. We conducted a study to assess the feasibility of MRI for the detection of prima...

    Authors: Nai-Yuan Wu, Hui-Cheng Cheng, James S Ko, Yu-Chen Cheng, Po-Wei Lin, Wei-Chan Lin, Cheng-Yen Chang and Der-Ming Liou
    Citation: BMC Cancer 2011 11:242
    Content type: Research article Published on:

  12. There is growing interest in the collection and use of patient-reported outcome measures (PROMs) to support clinical decision making in patients with non-small cell lung cancer (NSCLC). However, an overview of...

    Authors: Kuan Liao, Tianxiao Wang, Jake Coomber-Moore, David C Wong, Fabio Gomes, Corinne Faivre-Finn, Matthew Sperrin, Janelle Yorke and Sabine N van der Veer
    Citation: BMC Cancer 2022 22:1076
    Content type: Research Published on:

  15. Tumor-associated macrophages (TAMs) play an important role in growth, progression and metastasis of tumors. In non-small cell lung cancer (NSCLC), TAMs' anti-tumor or pro-tumor role is not determined. Macropha...

    Authors: Junliang Ma, Lunxu Liu, Guowei Che, Nanbin Yu, Fuqiang Dai and Zongbing You
    Citation: BMC Cancer 2010 10:112
    Content type: Research article Published on:

  16. Semaphorins have been found to play important roles in multiple malignancy-related processes. However, the role of Semaphorin 4B (SEMA4B) in lung cancer remains unclear. Here, we aimed to explore the biologica...

    Authors: Jun Jiang, Yuan Lu, Fang Zhang, Tao Pan, Zhipei Zhang, Yi Wan, Xinling Ren and Rui Zhang
    Citation: BMC Cancer 2022 22:632
    Content type: Research Published on:

  17. To select optimal candidates for limited lung resection, it is necessary to accurately differentiate the non-invasive tumors from other small-sized lung cancer. Urinary N1, N12-diacetylspermine (DiAcSpm) has been...

    Authors: Yusuke Takahashi, Hirotoshi Horio, Koji Sakaguchi, Kyoko Hiramatsu and Masao Kawakita
    Citation: BMC Cancer 2015 15:65
    Content type: Research article Published on:

  18. Locally recurrent non-small cell lung cancer (NSCLC) poses a great challenge to physicians. This study aimed to explore the efficacy and safety of the combination of brachytherapy and docetaxel and cisplatin f...

    Authors: Xiaojuan Yu, Jin Li, Xiaoming Zhong and Jingdong He
    Citation: BMC Cancer 2015 15:656
    Content type: Research article Published on:

  19. Octamer-binding transcription factor 4A (OCT4A) is essential for cell pluripotency and reprogramming both in humans and mice. To date, however, the function of human OCT4 in somatic and/or tumour tissues is la...

    Authors: Seijiro Koshimune, Mitsuko Kosaka, Nobuhiko Mizuno, Hiromasa Yamamoto, Tomoyuki Miyamoto, Kohta Ebisui, Shinichi Toyooka and Aiji Ohtsuka
    Citation: BMC Cancer 2020 20:521
    Content type: Research article Published on:

  20. Mitochondria, which serve as the fundamental organelle for cellular energy and metabolism, are closely linked to the growth and survival of cancer cells. This study aims to identify and assess Sideroflexin1 (S...

    Authors: Wenting Liu, Qingwu Du, Ting Mei, Jingya Wang, Dingzhi Huang and Tingting Qin
    Citation: BMC Cancer 2024 24:94
    Content type: Research Published on:

  21. Significant advancements in improving ovarian cancer (OC) outcomes have been limited over the past decade. To predict prognosis and improve outcomes of OC, we plan to develop and validate a robust prognosis si...

    Authors: Meixuan Wu, Sijia Gu, Jiani Yang, Yaqian Zhao, Jindan Sheng, Shanshan Cheng, Shilin Xu, Yongsong Wu, Mingjun Ma, Xiaomei Luo, Hao Zhang, Yu Wang and Aimin Zhao
    Citation: BMC Cancer 2024 24:267
    Content type: Research Published on:

  22. Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-associated deaths and a majority of its histological type is manifested as serous ovarian cancer (SOC). In this study, we investigat...

    Authors: Yijing He, Ting Li, Jue Liu, Qiong Ou and Junlin Zhou
    Citation: BMC Cancer 2020 20:116
    Content type: Research article Published on:

  23. Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Here...

    Authors: Cheng Chen, Yang Tang, Wen-Dong Qu, Xu Han, Jie-Bin Zuo, Qing-Yong Cai, Gang Xu, Yong-Xiang Song and Xi-Xian Ke
    Citation: BMC Cancer 2021 21:619
    Content type: Research Published on:

  24. We aimed to evaluate the prognostic value of quality of life (QOL) for predicting survival among disease-free survivors of surgically-treated lung cancer after the completion of cancer treatment.

    Authors: Young Ho Yun, Young Ae Kim, Jin Ah Sim, Ae Sun Shin, Yoon Jung Chang, Jongmog Lee, Moon Soo Kim, Young Mog Shim and Jae lll Zo
    Citation: BMC Cancer 2016 16:505
    Content type: Research article Published on:

  25. N6-methyladenosine (m6A) modification and long non-coding RNAs (lncRNAs) play pivotal roles in gastric cancer (GC) progression. The emergence of immunotherapy in GC has created a paradigm shift in the approach...

    Authors: Yi Wang, Gui-Qi Zhu, Di Tian, Chang-Wu Zhou, Na Li, Ying Feng and Meng-Su Zeng
    Citation: BMC Cancer 2022 22:316
    Content type: Research Published on:

  26. Obstructive sleep apnea (OSA) is associated with increased risk of lung cancer mortality. Nevertheless, little is known about the underlying molecular mechanisms. This research aimed to investigate differentia...

    Authors: Li-Da Chen, Li Lin, Ji-Zhi Chen, Yang Song, Wei-Liang Zhang, Huang-Yu Li, Jia-Min Luo and Xiao-Bin Zhang
    Citation: BMC Cancer 2024 24:41
    Content type: Research Published on:

  27. Following the recommendation of lung cancer screening in the US, screening committees in several European countries are reviewing the evidence for implementing national programmes. However, inadequate particip...

    Authors: Samantha L. Quaife, Charlotte Vrinten, Mamta Ruparel, Samuel M. Janes, Rebecca J. Beeken, Jo Waller and Andy McEwen
    Citation: BMC Cancer 2018 18:497
    Content type: Research article Published on:

  28. KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23–35% and 13–20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, i...

    Authors: Koichi Sato, Hiroaki Akamatsu, Yasuhiro Koh, Koichi Ogawa, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Chiyoe Kitagawa, Tomoya Kawaguchi and Nobuyuki Yamamoto
    Citation: BMC Cancer 2022 22:1148
    Content type: Research Published on:

  29. Calcium-activated nucleotidase 1 (CANT1), functions as a calcium-dependent nucleotidase with a preference for UDP. However, the potential clinical value of CANT1 in lung adenocarcinoma (LA) has not been fully ...

    Authors: Qiwei Yao, Yilin Yu, Zhiping Wang, Mengyan Zhang, Jiayu Ma, Yahua Wu, Qunhao Zheng and Jiancheng Li
    Citation: BMC Cancer 2022 22:117
    Content type: Research Published on:

  30. Bladder cancer (BC) is one of the most common malignant diseases and the most common causes of cancer death worldwide. Immunotherapy has opened new avenues for precision treatment of bladder tumours, and immun...

    Authors: Pengyu Hui, Feng Ni, Liang Zheng, Lei Jia and Zhe Wang
    Citation: BMC Cancer 2023 23:355
    Content type: Research Published on:

  31. CANT1, as calcium-activated protein nucleotidase 1, is a kind of phosphatase. It is overexpressed in some tumors and related to poor prognosis, but few studies explore its function and carcinogenic mechanism i...

    Authors: Ting Liu, Zhi-zhao Li, Lei Sun, Kun Yang, Jia-min Chen, Xiao-yi Han, Li-ming Qi, Xin-gang Zhou and Peng Wang
    Citation: BMC Cancer 2023 23:1007
    Content type: Research Published on:

  32. KRAS mutations occur frequently in advanced non-small cell lung cancer (aNSCLC); the G12C mutation is the most prevalent. Alterations in STK11 or KEAP1 commonly co-occur with KRAS mutations in aNSCLC. Using real...

    Authors: Cristina Julian, Navdeep Pal, Anda Gershon, Marie Evangelista, Hans Purkey, Peter Lambert, Zhen Shi and Qing Zhang
    Citation: BMC Cancer 2023 23:352
    Content type: Research Published on:

  33. Recent studies showed heterogeneity in stage IVB patients. However, few studies focused on the prognosis of supraclavicular metastatic ovarian cancer. This study aimed to explore the prognostic factors and the...

    Authors: Chenlian Quan, Xiaojun Chen, Hao Wen, Xiaohua Wu and Jin Li
    Citation: BMC Cancer 2024 24:565
    Content type: Research Published on:

  34. This study aimed to investigate the association between baseline serum tumor markers (STMs) (carcinoembryonic antigen [CEA], neuron-specific enolase [NSE], cytokeratin-19 fragment [CYFRA21-1], carbohydrate ant...

    Authors: Jian Huang, Yi Xiao, Yubin Zhou, Huiyin Deng, Zihao Yuan, Longyan Dong, Jun Lan, Xiane Li, Gaijiao Liu, Hao Hu, Shaohong Huang and Xiongwen Yang
    Citation: BMC Cancer 2023 23:812
    Content type: Research Published on:

  35. Mutations in the TP53 (Tumour Protein 53) gene can lead to expression of mutant p53 proteins that accumulate in cancer cells and can induce circulating p53 antibodies in cancer patients. Our aim was to evaluate t...

    Authors: Manlio Mattioni, Silvia Soddu, Andrea Prodosmo, Paolo Visca, Salvatore Conti, Gabriele Alessandrini, Francesco Facciolo and Lidia Strigari
    Citation: BMC Cancer 2015 15:148
    Content type: Research article Published on:

  36. Cervical cancer is one of the most frequent malignancies in women, particularly metastasis resulting in a poor prognosis. However, the clinical characteristics of cervical cancer patients with advanced liver m...

    Authors: Hang Liu, Xiangsen Ye, Di Li, Qian Yao and Yan Li
    Citation: BMC Cancer 2021 21:421
    Content type: Research article Published on:

  37. The Lung Cancer Exercise Training Study (LUNGEVITY) is a randomized trial to investigate the efficacy of different types of exercise training on cardiorespiratory fitness (VO2peak), patient-reported outcomes, and...

    Authors: Lee W Jones, Neil D Eves, William E Kraus, Anil Potti, Jeffrey Crawford, James A Blumenthal, Bercedis L Peterson and Pamela S Douglas
    Citation: BMC Cancer 2010 10:155
    Content type: Study protocol Published on:

  38. Microparticles (MPs) are extracellular vesicles that are associated with cancer development and progression. Advanced non-small cell lung cancer (NSCLC) still shows disease progression after multiple lines of ...

    Authors: Tingting Liu, Jiang Wang, Tao Li, Pengfei Cui, Baicun Hou, Chunxiao Zhuang, Ge Wei, Sujie Zhang, Hongxia Li and Yi Hu
    Citation: BMC Cancer 2021 21:939
    Content type: Research Published on:

  39. Increase of Serum amyloid A (SAA) level has been observed in patients with a variety of cancers. The objective of this study was to determined whether SAA level could be used as a prognostic parameter in patie...

    Authors: Jun-Ye Wang, Yu-Zhen Zheng, Juan Yang, Yue-Hao Lin, Shu-Qin Dai, Ge Zhang and Wan-Li Liu
    Citation: BMC Cancer 2012 12:365
    Content type: Research article Published on:

  40. Metastasis of colorectal cancer (CRC) is directly linked to patient survival. We previously identified the novel gene Metastasis Associated in Colon Cancer 1 (MACC1) in CRC and demonstrated its importance as m...

    Authors: Viktor H Koelzer, Pia Herrmann, Inti Zlobec, Eva Karamitopoulou, Alessandro Lugli and Ulrike Stein
    Citation: BMC Cancer 2015 15:160
    Content type: Research article Published on:

  41. Recent studies have reported TIMs play an important role in tumors progression or regression, but the effect of TIMs in biliary tract cancer remains unclear. The aim of this study is to investigate the prognos...

    Authors: Xiaobo Bo, Jie Wang, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Yueqi Wang, Houbao Liu and Jiejie Xu
    Citation: BMC Cancer 2018 18:313
    Content type: Research article Published on:

  43. The features and survival of stage IV breast cancer patients with different metastatic sites are poorly understood. This study aims to examine the clinicopathological features and survival of stage IV breast c...

    Authors: Ru Wang, Yayun Zhu, Xiaoxu Liu, Xiaoqin Liao, Jianjun He and Ligang Niu
    Citation: BMC Cancer 2019 19:1091
    Content type: Research article Published on:

  44. There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This stu...

    Authors: Nan Bi, Lipin Liu, Jun Liang, Shixiu Wu, Ming Chen, Changxing Lv, Lujun Zhao, Anhui Shi, Wei Jiang, Yaping Xu, Zongmei Zhou, Jingbo Wang, Wenqing Wang, Dongfu Chen, Zhouguang Hui, Jima Lv…
    Citation: BMC Cancer 2020 20:278
    Content type: Research article Published on:

  46. The purpose of our research was to determine the prognostic impact and clinicopathological feature of c-MYC and β-catenin overexpression in colorectal cancer (CRC) patients.

    Authors: Kyu Sang Lee, Yoonjin Kwak, Kyung Han Nam, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Woo Ho Kim and Hye Seung Lee
    Citation: BMC Cancer 2016 16:730
    Content type: Research article Published on:

  47. Programmed Cell Death-1/ Programmed Death-ligand 1 (PD-1 / PD-L1) inhibitor therapies targeting immunocytes induce persistent tumor remission in various cancers. However, the appropriate biomarkers for the the...

    Authors: Xiaoyue Du, Shaodi Wen, Run Shi, Jingwei Xia, Ruotong Wang, Yihan Zhang, Banzhou Pan, Xiaoliu Wu, Wei Zhu, Jifeng Feng, Xin Wang and Bo Shen
    Citation: BMC Cancer 2023 23:83
    Content type: Research Published on:

  48. E2F1 transcription factor plays a vital role in the regulation of diverse cellular processes including cell proliferation, apoptosis, invasion and metastasis. E2F1 overexpression has been demonstrated in small...

    Authors: Zunling Li, Yanxia Guo, Hanming Jiang, Tingguo Zhang, Changzhu Jin, Charles YF Young and Huiqing Yuan
    Citation: BMC Cancer 2014 14:276
    Content type: Research article Published on:

  50. Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) has been identified as a putative cancer stem cell (CSC) marker in breast cancer. However, the clinicopathological and prognostic significance of this protei...

    Authors: Ying Liu, Dong-lai Lv, Jiang-jie Duan, Sen-lin Xu, Jing-fang Zhang, Xiao-jun Yang, Xia Zhang, You-hong Cui, Xiu-wu Bian and Shi-cang Yu
    Citation: BMC Cancer 2014 14:444
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us